Discovery of Imidazo[2,1-<i>b</i>]thiazole HCV NS4B Inhibitors Exhibiting Synergistic Effect with Other Direct-Acting Antiviral Agents
Ningyu Wang(Southwest Jiaotong University), Luoting Yu(Sichuan University), Hong Tang(Jiangnan University), Ying Xu(Chengdu Medical College), Chao Gao(Sichuan University), Xinyu You(State Key Laboratory of Biotherapy), Shengyong Yang(Sichuan University), Kun-Jie Xiao(Sichuan University), Xiu‐Xiu Zeng(Sichuan University), Li Liu(Sichuan University), Zhihao Liu(Sichuan University), Lidan Zhang(Sichuan University), Xuejiao Song(Sichuan University), Cuiting Peng(Sichuan University), Qian Lei(Southwest University), Yong Xia(Guiyang Medical University), Tinghong Ye(Sichuan University), Ying Xiong(China University of Geosciences), Weiqiong Zuo(Sichuan University)
Cited by 43
Related Papers
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.6k
SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
|Science|2021|449
Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses
|Cellular & Molecular Biology Letters|2022|170
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
|PLoS ONE|2014|131
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
|Journal of Medicinal Chemistry|2021|116